4.6 Article

Accuracy of the functional, flow cytometer-based Emo-Test HIT Confirm® for the diagnosis of heparin-induced thrombocytopenia

期刊

THROMBOSIS RESEARCH
卷 203, 期 -, 页码 22-26

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2021.04.017

关键词

Heparin; adverse effects; Flow cytometry; methods; Thrombocytopenia; chemically induced; Thrombocytopenia; diagnosis

资金

  1. Swiss National Science Foundation [179334]

向作者/读者索取更多资源

The study investigated a rapid flow cytometer-based assay for the diagnostic accuracy of HIT, showing high specificity but limited sensitivity in verifying HIT patients. The results suggest that other rapid functional assays should be studied in appropriately designed diagnostic accuracy studies.
Introduction: Rapid functional assays have been proposed to overcome the limitations of washed platelet assays in the work-up of patients with suspected heparin-induced thrombocytopenia (HIT). Data on the diagnostic accuracy are, however, scarce and conflicting. We aimed to study the diagnostic accuracy of a rapid, flow cytometerbased assay and to explore sources of variability. Material and methods: Frozen serum samples of 103 consecutive patients, evaluated for suspected HIT at our institution in 2017, and characterized with 4Ts score, IgG-PF4/heparin ELISA (GTI), HemosIL (R) Acustar (IgG), as well as heparin-induced platelet activation test (HIPA), were further tested using HIT Confirm, determining Pselectin release of donor platelets after incubation with patient's serum. The diagnosis of HIT was defined as a positive HIPA result. Results: HIT was confirmed in 15 out of 103 patients corresponding to a prevalence of 14.6%. HIT Confirm was positive in 11 patients (10.7%), negative in 88 patients (85.4%), and inconclusive in 4 patients (3.9%). According to the intention-to-diagnose principle, the number of true positives was 9, the number of true negatives 83, the number of false negatives was 6, the number of false positives 5. This corresponds to a sensitivity of 60.0%, and a specificity of 94.3%. Modifications of the test did not improve sensitivity. Conclusions: The rapid, flow cytometer-based assay HIT Confirm is able to verify HIT in positive patient samples but cannot rule-out HIT in clinical practice. Other rapid functional assays shall be studies in appropriately designed diagnostic accuracy studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据